Document:

EX-10.1

 Exhibit 10.1 

Executive Version 
 BIOMED
REALTY TRUST, INC. 
 RESTRICTED CASH AWARD GRANT NOTICE AND 

RESTRICTED CASH AWARD AGREEMENT 

BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), hereby grants to the individual listed below
(“Participant”), a restricted cash award with an aggregate value set forth below. This award (this “Award”) is subject to all of the terms and conditions as set forth herein and in the Restricted Cash Award
Agreement attached hereto as Exhibit A (the “Restricted Cash Agreement”) and the Restricted Cash Award Agreement Vesting Schedule attached hereto as Exhibit B, each of which is incorporated herein by reference. 

 

			
	Participant:	  	  

		
	Grant Date:	  	  

		
	Restricted Cash Amount:	  	 $

		
	Vesting Schedule:	  	Subject to the terms of the Restricted Cash Agreement, the Award shall vest as set forth on Exhibit B attached hereto.

 By his or her signature below, Participant agrees to be bound by the terms and conditions of the Restricted
Cash Agreement and this Grant Notice. Participant has reviewed the Restricted Cash Agreement and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands
all provisions of the same. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator (as defined in Exhibit B) upon any questions arising under the Restricted Cash Agreement or
this Grant Notice. 
  

							
	BIOMED REALTY TRUST, INC.	  	PARTICIPANT
				
	By:	 	  
	  	By:	  	  

	Print Name:	 	  
	  	Print Name:	  	  

	Title:	 	  
	  		  	

 Executive Version 
  

 EXHIBIT A 

TO RESTRICTED CASH AWARD GRANT NOTICE 

RESTRICTED CASH AWARD AGREEMENT 

Pursuant to the Restricted Cash Award Grant Notice (the “Grant Notice”) to which this Restricted Cash Award Agreement (this
“Agreement”) is attached, the Company has granted to Participant the right to receive the Restricted Cash Amount set forth in the Grant Notice, subject to all of the terms and conditions set forth in this Agreement and the Grant
Notice. 
 ARTICLE I 

AWARD OF RESTRICTED CASH 

1.1 Award. 
 (a)
Award. In consideration of Participant’s continued employment with the Company or any subsidiary thereof and for other good and valuable consideration, the Company hereby grants to Participant the right to receive the Restricted Cash
Amount set forth in the Grant Notice. The Award represents an unsecured obligation of the Company, payable only from the general assets of the Company and its subsidiaries. 

(b) Vesting. The Award shall vest in accordance with Exhibit B to the Grant Notice. 

1.2 Distribution of Restricted Cash Amount. 

(a) Payment of Restricted Cash Amount. Subject to the terms and conditions of this Agreement, within ten (10) days following the
date on which all or any portion of the Restricted Cash Amount vests pursuant to Exhibit B to the Grant Notice, the Company shall pay to Participant (or in the event of Participant’s death, to his or her estate), in cash, such portion of
the Restricted Cash Amount that vested as of such vesting date. 
 (b) Changes to Distribution Timing. The time of distribution of the
Restricted Cash Amount may not be changed, except as may be permitted by the Administrator in accordance with Section 409A of the Code and the Treasury Regulations thereunder. No payment under this Agreement shall be made at a time earlier than
that provided for in this Agreement unless such payment is (i) an acceleration of payment permitted to be made under Treasury Regulation §1.409A-3(j)(4) or (ii) a payment that would otherwise not be subject to additional taxes and
interest under Section 409A. 
 1.3 Tax Withholding. The Company shall not be obligated to pay the Restricted Cash Amount or any
portion thereof to Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable
with respect to the taxable income of Participant resulting from the vesting of the Restricted Cash Amount, the payment thereof or any other taxable event related to the Award (the “Tax Withholding Obligation”). To the maximum
extent permitted by applicable law, the Company has the authority to deduct or withhold by the deduction of such amount as is necessary to satisfy any Tax Withholding Obligation from other compensation payable to with respect to any taxable event
arising from the Award. 

  
 A-1 

 Executive Version 
  

 1.4 Award and Interests Not Transferable. This Award may not be sold, pledged,
assigned or transferred in any manner other than by will or the laws of descent and distribution. This Award and the rights and privileges conferred hereby shall not be liable for the contracts or engagements of Participant or his or her successors
in interest and shall not be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment,
garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 

ARTICLE II 
 OTHER
PROVISIONS 
 2.1 No Right to Continued Employment or Awards. 

(a) Nothing in the Grant Notice or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company
or any subsidiary or shall interfere with or restrict in any way the rights of the Company and any subsidiary, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever,
except to the extent expressly provided otherwise in a written agreement between the Company or any subsidiary and Participant. 
 (b) The
grant of the Award is a one-time benefit and does not create any contractual or other right to receive a grant of Awards or benefits in lieu of Awards in the future. Future grants, if any, will be at the sole discretion of the Company. In addition,
the value of the Award is an extraordinary item of compensation outside the scope of any employment contract. As such, the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end
of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 
 2.2 Notices. Any notice to
be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s corporate headquarters or to the then-current email address for the Secretary of the Company,
and any notice to be given to Participant shall be addressed to Participant at the most recent physical or email address for Participant listed in the Company’s personnel records. By a notice given pursuant to this Section 2.2, either
party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a
post office or branch post office regularly maintained by the United States Postal Service. 
 2.3 Titles. Titles are provided herein
for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. 
 2.4 Governing Law;
Severability. The laws of the State of Maryland shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of
laws. THE PARTIES EXPRESSLY WAIVE ANY RIGHT THEY HAVE OR MAY HAVE TO A JURY TRIAL OF ANY SUCH SUIT, ACTION OR PROCEEDING. If any one or more provisions of this Agreement shall for any reason be held invalid or unenforceable, it is the specific
intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable. 

  
 A-2 

 Executive Version 
  

 2.5 Tax Representations. Participant has reviewed with Participant’s own tax
advisors the federal, state, local and foreign tax consequences of this Award and the transactions contemplated by the Grant Notice and this Agreement. Participant is relying solely on such advisors and not on any statements or representations of
the Company or any of its agents. Participant understands that Participant (and not the Company) shall be responsible for Participant’s own tax liability that may arise as a result of this Award or the transactions contemplated by this
Agreement. 
 2.6 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple
assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement shall be binding upon Participant and his or her heirs, executors,
administrators, successors and assigns. 
 2.7 Amendment, Suspension and Termination. This Agreement may be wholly or partially
amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator; provided that no amendment, modification, suspension or termination of this Agreement shall impair any rights or obligations under
this Agreement in any material way without the prior written consent of Participant. 
 2.8 Paperless Administration. By accepting
this Award, Participant hereby agrees to receive documentation related to the Award by electronic delivery, such as a system using an internet website or interactive voice response, maintained by the Company or a third party designated by the
Company. 
 2.9 Entire Agreement. The Grant Notice and this Agreement constitute the entire agreement of the parties and supersede in
their entirety all oral, implied or written promises, statements, understandings, undertakings and agreements between the Company and Participant with respect to the subject matter hereof, including without limitation, the provisions of any
employment agreement or offer letter regarding incentive awards to be awarded to Participant by the Company, or any other oral, implied or written promises, statements, understandings, undertakings or agreements by the Company or any of its
representatives regarding incentive awards to be awarded to Participant by the Company. 
 2.10 Section 409A. 

(a) Notwithstanding any other provision of this Agreement or the Grant Notice, this Agreement and the Grant Notice shall be interpreted in
accordance with, and incorporate the terms and conditions required by, Section 409A of the Code (together with any Treasury Regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or
other guidance that may be issued after the Grant Date, “Section 409A”). 
 (b) Notwithstanding anything herein to the
contrary, to the extent any portion of the Restricted Cash Amount payable to Participant pursuant to this Agreement is treated as non-qualified deferred compensation subject to Section 409A, then no amount shall be payable to Participant as a
result of his or her Qualifying Termination (as defined in Exhibit B) pursuant to Section 2 of Exhibit B unless such termination of employment constitutes a “separation from service” with the Company (as such term is
defined in Treasury Regulation Section 1.409A-1(h) and any successor provision thereto) (a “Separation from Service”). For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation
Section 1.409A-2(b)(2)(iii)), each payment that Participant may be eligible to receive under this Agreement shall be treated as a separate and distinct payment. 

(c) If Participant is a “specified employee” (as determined in accordance with Section 409A(a)(2)(B)(i) of the Code and Treasury
Regulation Section 1.409A-1(i)) on the date of his or her Separation from Service, the payment of the Restricted Cash Amount or any portion thereof to 

  
 A-3 

 Executive Version 
  

 
Participant upon and as a result of such Separation from Service shall be delayed to the extent necessary to avoid a prohibited distribution under Section 409A(2)(B)(i) of the Code, and such
amount shall be distributed to Participant on the earlier of (i) the expiration of the six-month period measured from the date of Participant’s Separation from Service, (ii) the date of Participant’s death, or (iii) such
earlier date as is permitted under Section 409A and the Treasury Regulations thereunder. 

  
 A-4 

 Executive Version 
  

 EXHIBIT B 

TO RESTRICTED CASH AWARD GRANT NOTICE 

RESTRICTED CASH AWARD AGREEMENT 

VESTING SCHEDULE 

Capitalized terms used in this Exhibit B and not defined in Section 4 below shall have the meanings given them in the Agreement to
which this Exhibit B is attached. 
 1. Vesting. The Award shall vest in three (3) equal installments on each of
January 1, 2017, January 1, 2018 and January 1, 2019. 
 2. Effect of a Qualifying Termination. In the event
Participant experiences a Qualifying Termination, then Participant shall immediately vest in any unvested portion of the Award upon such Qualifying Termination. The provisions of this Section 2, and not the provisions of the Severance Plan or
the Change in Control and Severance Agreement, shall govern the accelerated vesting of the Award in the event of Participant’s Qualifying Termination. 

3. Forfeiture. In the event that Participant’s employment is terminated other than as a result of a Qualifying Termination, then
the unvested portion of the Award shall automatically and without further action be cancelled and forfeited by Participant, and Participant shall have no further right or interest in or with respect to such portion of the Award. 

4. Definitions. For purposes of this Exhibit B, the following terms shall have the meanings given below: 

(a) “Administrator” shall mean the Compensation Committee (the “Compensation Committee”) of the Board of
Directors of the Company (the “Board”), or the Board in the event there is no Compensation Committee. Notwithstanding the foregoing, following the date of the closing of the transactions contemplated by the Merger Agreement, the
term “Administrator” as used in this Agreement shall refer to the Board of Directors of the successor to the Company, or in the event there is no such Board of Directors, [the Chief Executive Officer]1 of BioMed Realty, L.P., a Maryland limited partnership. 
 (b) “Cause”
shall mean the occurrence of any one or more of the following events unless Participant fully corrects the circumstances constituting Cause within thirty (30) days following the date written notice is delivered to Participant which specifically
identifies the circumstances constituting Cause (provided such circumstances are capable of correction): 
 (i) Participant’s willful
and continued failure to substantially perform his or her duties with the Company (other than any such failure resulting from Participant’s incapacity due to physical or mental illness), after a written demand for substantial performance is
delivered to Participant by the Board, which demand specifically identifies the manner in which the Board believes that Participant has not substantially performed his or her duties; 

 
  

	1 	To be replaced with “General Partner” for the agreement with the Chief Executive Officer. 

  
 B-1 

 Executive Version 
  

 (ii) Participant’s willful commission of an act of fraud or dishonesty resulting in
economic or financial damage to the Company; 
 (iii) Participant’s conviction of, or entry by Participant of a guilty or no contest
plea to, the commission of a felony or a crime involving moral turpitude; 
 (iv) a willful breach by Participant of his or her fiduciary
duty to the Company which results in economic or other damage to the Company; or 
 (v) Participant’s willful and material breach of
Participant’s covenants set forth in Section 5(a) or 5(b) in the Change in Control and Severance Agreement. 
 For purposes of this
provision, no act or failure to act, on the part of Participant, shall be considered “willful” unless it is done, or omitted to be done, by Participant in bad faith or without reasonable belief that Participant’s action or omission
was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or
omitted to be done, by Participant in good faith and in the best interests of the Company. The cessation of employment of Participant shall not be deemed to be for Cause unless and until there shall have been delivered to Participant a copy of a
resolution duly adopted by the affirmative vote of not less than two-thirds of the entire membership of the Board at a meeting of the Board called and held for such purpose (after reasonable notice is provided to Participant and Participant is given
an opportunity, together with counsel for Participant, to be heard before the Board), finding that, in the good faith opinion of the Board, Participant is guilty of any of the conduct described in this Section 4(b), and specifying the
particulars thereof in detail; provided, that if Participant is a member of the Board, Participant shall not vote on such resolution nor shall Participant be counted in determining the “entire membership” of the Board. 

(c) “Change in Control and Severance Agreement” shall mean that certain Change in Control and Severance Agreement, dated as of
[            ], among the Company, the Partnership and Participant, as in effect on the Grant Date. 

(d) “Good Reason” shall mean the occurrence of any one or more of the following events without Participant’s prior
written consent, unless the Company fully corrects the circumstances constituting Good Reason within thirty (30) days following the date written notice is delivered to the Board by Participant which specifically identifies the circumstances
constituting Good Reason (provided such circumstances are capable of correction), after: 
 (i) a material diminution in Participant’s
base compensation; 
 (ii) a material diminution in Participant’s authority, duties or responsibilities, including a requirement that
Participant report to a [another] corporate officer or employee instead of reporting directly to the [Board][Chief Executive Officer of the Company]; provided, that, from and after the date that is thirty (30) days following the closing
of the transactions contemplated by the Merger Agreement, the consummation of the transactions contemplated by the Merger Agreement and any changes or modifications to Participant’s authority, duties or responsibilities which occur before, at
or after the consummation of the transactions contemplated by the Merger Agreement and which arise solely as a result of the Company ceasing to be a publicly-held company or becoming a subsidiary of Parent in connection with the consummation of the
transactions contemplated by the Merger Agreement, will not, in and of itself, constitute a “material diminution in Participant’s authority, duties or responsibilities (and, therefore, will not constitute Good Reason, under this Agreement;

  
 B-2 

 Executive Version 
  

 (iii) a material change in the geographic location at which Participant must perform his or
her duties; or 
 (iv) any other action or inaction that constitutes a material breach by the Company of its obligations to Participant
under the Change in Control and Severance Agreement. 
 Notwithstanding the foregoing, “Good Reason” shall only exist if
Participant shall have provided the Board with written notice within ninety (90) days of the initial occurrence of any of the foregoing events or conditions which specifically identifies the circumstances constituting Good Reason (provided such
circumstances are capable of correction), and the Company fails to eliminate the conditions constituting Good Reason within thirty (30) days after receipt of written notice of such event or condition from Participant. Participant’s
termination by reason of resignation from employment with the Company for Good Reason shall be treated as involuntary. Participant’s resignation from employment with the Company for Good Reason must occur within two (2) years following the
initial existence of the event or condition constituting Good Reason. The foregoing procedural requirements shall not apply to a resignation for Good Reason by Participant occurring pursuant to clause (ii) above during the thirty (30) day
period commencing on the date of the closing of the transactions contemplated by the Merger Agreement. 
 (e) “Merger
Agreement” means that certain Agreement and Plan of Merger dated as of October 7, 2015, by and among the REIT, the Partnership, BRE Edison Holdings, L.P., BRE Edison L.P. and BRE Edison Acquisition L.P. 

(f) “Qualifying Termination” means a termination of Participant’s employment with the Company or any of its subsidiaries
as a result of (i) Participant’s termination by the Company or any of its subsidiaries without Cause, (ii) Participant’s voluntary resignation for Good Reason, or (iii) any resignation of Participant’s employment for
any reason during the thirty (30) day period commencing on the date of the closing of the transactions contemplated by the Merger Agreement. 

(g) “Severance Plan” means the Company’s Severance Plan as in effect on the Grant Date. 

  
 B-3EX-10.2

 Exhibit 10.2 

EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT 

This Equity Award Acceleration and Share Restriction Agreement (this “Agreement”) is made and entered into as of
December 31, 2015 (the “Effective Date”), by and between BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and Alan D. Gold (“Holder”). 

R E C I T A L S 
 A.
WHEREAS, Holder currently holds the unvested restricted stock awards and unvested performance units described on Exhibit 1 attached hereto (collectively, the “Unvested Equity Awards”). 

B. WHEREAS, a portion of the Unvested Equity Awards are scheduled to vest on January 1, 2016, in accordance with their terms (the
“January 2016 Unvested Equity Awards”), which January 2016 Unvested Equity Awards are identified on Exhibit 1 attached hereto. 

C. WHEREAS, a portion of the Unvested Equity Awards are scheduled to vest after January 1, 2016, in accordance with their terms (the
“Additional Unvested Equity Awards”), which Additional Unvested Equity Awards are separately identified on Exhibit 1 attached hereto. 

D. WHEREAS, the Company has entered into that certain Agreement and Plan of Merger, dated as of October 7, 2015, among the Company, BioMed
Realty, L.P. (the “Partnership”) and BRE Edison Holdings, L.P. (“Parent”), BRE Edison L.P. and BRE Edison Acquisition L.P. (the “Merger Agreement”), pursuant to which the
Company will become a wholly-owned subsidiary of Parent. 
 E. WHEREAS, the Company has agreed to accelerate the vesting of the Unvested
Equity Awards so that such awards shall vest and/or be settled effective as of December 31, 2015, subject to Holder’s execution of this Agreement. 

NOW, THEREFORE, in consideration of the mutual promises herein contained, the Company and Holder agree as follows. 

1. TERM. The term of this Agreement shall commence on the Effective Date and shall continue until the first to occur of
(a) the closing of the transactions contemplated by the Merger Agreement (the “Closing”), (b) the date of Holder’s Qualifying Termination (as defined below), provided such Qualifying Termination occurs prior to
the Merger Termination Date (as defined below), or (c) the lapse of the Transfer Restrictions and the Forfeiture Restrictions set forth herein with respect to all shares of the Company’s common stock (the “Shares”)
issued to Holder upon the accelerated vesting of the Additional Unvested Equity Awards. Following the expiration of the term of this Agreement, the Transfer Restrictions and the Forfeiture Restrictions, if any, set forth herein shall lapse and no
longer apply. 
 2. ACCELERATED VESTING OF EQUITY AWARDS. Subject to Holder’s continued employment with the Company
through December 31, 2015: 
 2.1 The vesting of the January 2016 Unvested Equity Awards shall accelerate and such awards shall
become vested and/or settled in Shares effective as of December 31, 2015, in the amounts set forth on Exhibit 1 attached hereto (the “January 2016 Accelerated Equity Awards”); and 

2.2 The vesting of the Additional Unvested Equity Awards shall accelerate and such awards shall become vested and/or settled in Shares
effective as of December 31, 2015, in the amounts set forth on Exhibit 1 attached hereto (the “Additional Accelerated Equity Awards,” and together with the January 2016 Accelerated Equity Awards, the
“Accelerated Equity Awards”). 

  
 1 

 3. TRANSFER RESTRICTIONS.  

3.1 Unless Holder receives the Company’s prior written consent, the Holder shall not sell, assign, transfer, pledge, hypothecate,
encumber, or otherwise dispose of (collectively, “Transfer”) the Shares issued pursuant to the Additional Accelerated Equity Awards, and any attempted Transfer thereof is strictly prohibited and shall be null and void (the
“Transfer Restrictions”). Notwithstanding the forgoing sentence, for the avoidance of doubt, the Transfer Restrictions shall not apply to any Transfer expressly contemplated by the Merger Agreement. 

3.2 The Transfer Restrictions set forth in Section 3.1 above shall lapse and no longer apply following the date on which the
Additional Accelerated Equity Awards would have otherwise vested absent the acceleration of vesting set forth in Section 2 above pursuant to the Company’s 2004 Incentive Award Plan, as amended (the “2004 Plan”), the
award agreements issued thereunder pursuant to which such Additional Accelerated Equity Awards were granted (the “Award Agreements”) or the Change in Control and Severance Agreement (as defined below). 

3.3 Notwithstanding the forgoing, in the event that the Merger Agreement is terminated pursuant to its terms (the “Merger
Termination Date”) or (b) the Closing does not occur prior to April 8, 2016, the Company shall, upon Holder’s written request, waive the Transfer Restrictions to permit Holder’s sale of Shares issued to Holder with
respect to the Additional Accelerated Equity Awards to the extent necessary to assist Holder in meeting his or her federal and state income tax obligations arising as a result of the acceleration of the Additional Accelerated Equity Awards, as
determined by the Company in its reasonable good faith judgment. 
 4. REVESTING OF SHARES. 

4.1 Unless Holder’s employment is terminated prior to the Merger Termination Date as a result of a Qualifying Termination or
Holder’s voluntary termination for any reason, Holder hereby agrees that any Shares issued to Holder pursuant to the accelerated vesting of the Additional Accelerated Equity Awards pursuant to Section 2 above, the vesting of which was
performance-based, shall automatically and without further action by the Company or Holder, as of the Merger Termination Date, become “Unvested Shares” for purposes of this Agreement. Notwithstanding the foregoing, in the
event Holder’s employment is terminated for Cause prior to the Merger Termination Date, Holder shall immediately forfeit any and all Shares issued pursuant the Additional Accelerated Equity Awards pursuant to Section 2. 

4.2 Subject to the provisions of Sections 4.3 and 4.4 below, in the event of Holder’s termination of employment or service with the
Company or any of its subsidiaries for any reason following the Merger Termination Date, or in the event the Unvested Shares fail to vest pursuant to Section 4.3 because of the Company’s failure to satisfy the applicable performance
objectives under the applicable Award Agreement, all of the Unvested Shares, or such portion of the Unvested Shares that has failed to vest on the applicable vesting dates pursuant to Section 4.3, shall thereupon be forfeited immediately and
without any further action by the Company (the “Forfeiture Restriction”). Upon the occurrence of such a forfeiture, the Company shall become the legal and beneficial owner of the Unvested Shares and all rights and interests
therein or relating thereto, and the Company shall have the right to retain and transfer to its own name the number of Unvested Shares being forfeited by Holder. 

4.3 Following the Merger Termination Date, any Unvested Shares shall be released from the Forfeiture Restriction in accordance with the
performance-based vesting schedule set forth in the Award Agreement which previously governed the Additional Accelerated Equity Award pursuant to which such Unvested Shares were issued (the “Original Award Agreement”). As
soon as administratively practicable following the release of any Shares from the Forfeiture Restriction, the Company shall deliver to Holder the Shares so released. Holder (or the beneficiary or personal representative of Holder in the event of
Holder’s death or incapacity, as the case may be) shall deliver to the Company any representations or other documents or assurances as the Company or its representatives deem necessary or advisable in connection with any such delivery. 

  
 2 

 4.4 The Shares issued upon acceleration of the Additional Accelerated Equity Awards
pursuant to Section 2 above and Holder’s executed Stock Power and Assignment shall be held by the Company until such Shares are fully released from the Forfeiture Restriction (if applicable) and the Transfer Restrictions. In such event,
Holder shall not retain physical custody of any certificates representing Unvested Shares issued to Holder. Holder, by execution of this Agreement, shall be deemed to appoint, and does so appoint, the Company and each of its authorized
representatives as Holder’s attorney(s)-in-fact to effect any transfer of forfeited Unvested Shares to the Company as may be required pursuant to this Agreement, and to execute such representations or other documents or assurances as the
Company or such representatives deem necessary or advisable in connection with any such transfer. The Company, or its designee, shall not be liable for any act it may do or omit to do with respect to holding the Shares in escrow and while acting in
good faith and in the exercise of its judgment. 
 4.5 Except as otherwise provided herein, upon the vesting of, or issuance of the
Shares by the Company pursuant to the accelerated vesting of, the Accelerated Equity Awards, Holder shall have all the rights of a stockholder with respect to said Shares, subject to the restrictions herein, including the right to vote the Shares
and to receive all dividends or other distributions paid or made with respect to the Shares. 
 4.6 The Forfeiture Restriction on the
Unvested Shares shall not lapse if the lapsing of such restrictions would likely result in any of the following: 
 (a) a violation of the
restrictions or limitations on ownership provided for from time to time under the terms of the organizational documents of the Company; or 

(b) income to the Company or any other circumstance that could impair the Company’s status as a real estate investment trust, within the
meaning of Section 856 through 860 of the Code. 
 5. BONUS REPAYMENT. In the event of Holder’s voluntary resignation
other than for Good Reason prior to the Closing or the Merger Termination Date, as applicable, Holder agrees to repay to the Company within thirty (30) days following such termination of employment any annual cash bonus amount paid to Holder by
the Company with respect to the Company’s 2015 fiscal year. 
 6. BEST PAY AGREEMENT. This Agreement shall be subject to
the terms and conditions set forth in that certain letter agreement dated as of December 31, 2015, between Holder, the Company and BioMed Realty, L.P. related to certain potential reductions in the compensation payable to Holder in the event
that any payment or benefit received or to be received by Holder pursuant to the terms of any plan, arrangement or agreement (including any payment or benefit received in connection with a change of control or the termination of Holder’s
employment) would be subject (in whole or part) to the excise tax imposed under Section 4999 of the Internal Revenue Code of 1986, as amended. 

7. DEFINITIONS. For purposes of this Agreement, the following terms shall have the meanings given below: 

7.1 “Cause” shall have the meaning given to such term in the Change in Control and Severance Agreement. 

7.2 “Change in Control and Severance Agreement” means that certain Change in Control and Severance Agreement,
dated as of January 25, 2012, among the Company, the Partnership and Holder, as in effect on the Effective Date. 

  
 3 

 7.3 “Disability” shall mean the absence of Holder from
Holder’s duties with the Company on a full-time basis for ninety (90) consecutive days or on a total of one hundred eighty (180) days in any twelve (12) month period, in either case as a result of incapacity due to mental or
physical illness which is determined to be total and permanent by a physician selected by the Company and reasonably acceptable to Holder or Holder’s legal representative. 

7.4 “Good Reason” shall have the meaning given to such term in the Change in Control and Severance Agreement.

 7.5 “Qualifying Termination” means a termination of Holder’s employment with the Company or any of its
subsidiaries as a result of (i) Holder’s termination by the Company or any of its subsidiaries without Cause, (ii) Holder’s voluntary resignation for Good Reason, (iii) Holder’s death, or (iv) Holder’s
Disability. 
 8. RESTRICTIVE LEGENDS AND STOP-TRANSFER ORDERS. 

8.1 Legends. Holder understands and agrees that the Company may place the legend set forth below, or a similar legend, on any
stock certificate(s) evidencing Unvested Shares, if any, together with any other legends that may be required by state or federal securities laws, the Company’s organizational documents, any other agreement between such Holder and the Company
or any third party: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO FORFEITURE IN FAVOR OF THE COMPANY AND MAY BE TRANSFERRED
ONLY IN ACCORDANCE WITH THE TERMS OF A RESTRICTED STOCK AWARD AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 

As soon as administratively practicable following the release of any Unvested Shares from the Forfeiture Restriction, the Company shall remove
any such legends placed on the stock certificate(s), if any, evidencing the Unvested Shares. 
 8.2 Stop-Transfer Instructions.
Holder agrees that, to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate “stop-transfer” instructions to its transfer agent, if any, and if the Company transfers its own securities, it may
make appropriate notations to the same effect in its own records. The Company will not be required (a) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or
(b) to treat as owner of such Shares, or to accord the right to vote or pay dividends, to any purchaser or other transferee to whom such Shares have been so transferred. 

9. GENERAL PROVISIONS. 

9.1 Successors and Assigns, Assignment. The Company may assign any of its rights and obligations under this Agreement. Any
assignment of rights and obligations by any other party to this Agreement requires the Company’s prior written consent. This Agreement, and the rights and obligations of the parties hereunder, will be binding upon and inure to the benefit of
their respective successors, assigns, heirs, executors, administrators and legal representatives. 
 9.2 Right of Termination
Unaffected. Nothing in this Agreement will be construed to limit or otherwise affect in any manner whatsoever the right or power of the Company or any of its subsidiaries or affiliates to terminate Holder’s employment with the Company
or any of its subsidiaries or affiliates at any time for any reason or no reason, with or without Cause (it being understood that this Section 9.2 shall have no effect on the effectiveness of, and the obligations of the Company under, the 2004
Plan, the Award Agreements or the Change in Control and Severance Agreement). 

  
 4 

 9.3 Governing Law. This Agreement will be governed by and construed in accordance
with the laws of the State of Maryland, without giving effect to the principles of conflict of laws. THE PARTIES EXPRESSLY WAIVE ANY RIGHT THEY HAVE OR MAY HAVE TO A JURY TRIAL OF ANY SUCH SUIT, ACTION OR PROCEEDING. If any one or more provisions of
this Agreement shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable. 

9.4 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of
the Secretary of the Company at the Company’s corporate headquarters or to the then-current email address for the Secretary of the Company, and any notice to be given to Holder shall be addressed to Holder at the most recent physical or email
address for Holder listed in the Company’s personnel records. By a notice given pursuant to this Section 9.4, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly
given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 

9.5 Titles and Headings. The titles, captions and headings of this Agreement are included for ease of reference only and will be
disregarded in interpreting or construing this Agreement. Unless otherwise specifically stated, all references herein to “Sections” and “Exhibits” will mean “sections” and “exhibits” to this Agreement. 

9.6 Amendments and Waivers. This Agreement may be amended only by a written agreement executed by each of the parties hereto. No
amendment of or waiver of, or modification of any obligation under this Agreement will be enforceable unless set forth in a writing signed by the party against which enforcement is sought. Any amendment effected in accordance with this
Section 9.6 will be binding upon all parties hereto and each of their respective successors and assigns. No delay or failure to require performance of any provision of this Agreement shall constitute a waiver of that provision as to that or any
other instance. No waiver granted under this Agreement as to any one provision herein shall constitute a subsequent waiver of such provision or of any other provision herein, nor shall it constitute the waiver of any performance other than the
actual performance specifically waived. 
 9.7 Severability. If any provision of this Agreement shall be found by any
arbitrator or court of competent jurisdiction to be invalid or unenforceable, then the parties hereby waive such provision to the extent of its invalidity or unenforceability, and agree that all other provisions in this Agreement shall continue in
full force and effect. 
 9.8 Binding Nature. This Agreement shall be binding upon, and inure to the benefit of, the successors
and personal representatives of the respective parties hereto. 
 9.9 Entire Agreement. This Agreement (together with the other
documents referenced therein) constitutes the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersedes all prior understandings and agreements, whether oral or written, between or among
the parties hereto with respect to the specific subject matter hereof and thereof. 
 9.10 Further Assurances. The parties
agree to execute such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement. 

  
 5 

 9.11 Counterparts; Facsimile Signatures. This Agreement may be executed in any
number of counterparts, each of which when so executed and delivered will be deemed an original, and all of which together shall constitute one and the same agreement. This Agreement may be executed and delivered by facsimile and upon such delivery
the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 
 9.12
Tax Representations. Holder has reviewed with Holder’s own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Holder is relying solely on such
advisors and not on any statements or representations of the Company or any of its agents. Holder understands that Holder (and not the Company) shall be responsible for Holder’s own tax liability that may arise as a result of this investment or
the transactions contemplated by this Agreement. 
 9.13 Withholding. All amounts payable to Holder under this Agreement shall
be subject to any and all federal, state, local and foreign taxes required to be withheld pursuant to applicable law. 

[SIGNATURE PAGE FOLLOWS] 

  
 6 

 In Witness Whereof, the parties hereto have executed this Equity Award Acceleration and
Share Restriction Agreement as of the date first written above. 
  

									
	HOLDER:	 		 	COMPANY:
			
	ALAN D. GOLD	 		 	BIOMED REALTY TRUST, INC.
					
	By:	 	 /s/ Alan D. Gold
	 		 	By:	 	 /s/ Jonathan P. Klassen

			
	Address:	 		 	 Name: Jonathan P. Klassen
 Title:
EVP, General Counsel and Secretary

				
		 		 		 	 Address: 17190 Bernardo Center Drive

San Diego, CA 92128

 LIST OF EXHIBITS 
  

			
	Exhibit 1:	  	Unvested Equity Awards
	Exhibit 2:	  	Stock Power and Assignment Separate from Stock Certificate

 EXHIBIT 1 

UNVESTED EQUITY AWARDS 
  

							
	 January 2016 Unvested Equity Awards
	 
	 Grant Date
	  	Restricted Stock or
Performance Units	  	Number of Shares/Units (at Maximum
Value) to be Accelerated	 
	 1/25/2012
	  	Restricted Stock	  	 	24,594	  
	 1/16/2013
	  	Restricted Stock	  	 	25,065	  
	 1/15/2014
	  	Restricted Stock	  	 	26,738	  
	 1/28/2015
	  	Restricted Stock	  	 	22,493	  
	 1/16/2013
	  	Performance Units	  	 	100,260	  

  

									
	 Additional Unvested Equity Awards

	 Grant Date
	  	 Restricted Stock

or Performance

Units
	  	Number of
Shares/Units (at
Maximum Value)
to be Accelerated	 	  	 Vesting Schedule Absent Acceleration

	 1/16/2013
	  	Restricted Stock	  	 	25,065	  	  	25,065 Shares on 1/1/2017
	 1/15/2014
	  	Restricted Stock	  	 	53,476	  	  	26,738 Shares on each of 1/1/2017 and 1/1/2018
	 1/28/2015
	  	Restricted Stock	  	 	67,479	  	  	22,493 Shares on each of 1/1/2017, 1/1/2018 and 1/1/2019
	 1/15/2014
	  	Performance Units	  	 	213,900	  	  	1/1/2017
	 1/28/2015
	  	Performance Units	  	 	179,944	  	  	1/1/2018

 The performance unit awards shall vest as determined under the applicable Award Agreements for such performance units, except
that: 
  

	 	•	 	With respect to the performance unit awards with an original Measurement Date (as defined in the Award Agreement for such performance units) of December 31, 2015, the Determination Date shall be deemed to be
December 31, 2015. 

  

	 	•	 	With respect to the performance unit awards with an original Measurement Date (as defined in the Award Agreement for such performance units) of December 31, 2016 or December 31, 2017, the Measurement Date and
the Determination Date shall be deemed to be December 31, 2015 and the Ending Average Market Value of the Company’s common stock shall be deemed to be $23.75 per share. 

 EXHIBIT 2 

STOCK POWER AND ASSIGNMENT 

SEPARATE FROM CERTIFICATE 
 FOR VALUE
RECEIVED and pursuant to that certain Equity Award Acceleration and Share Restriction Agreement dated as of December 31, 2015 (the “Agreement”), the undersigned hereby sells, assigns and transfers unto
                    ,              shares of the common stock, $0.01 par value per share,
of BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), standing in the undersigned’s name on the books of the Company represented by Certificate No(s).         
delivered herewith, and does hereby irrevocably constitute and appoint the Secretary of the Company as the undersigned’s attorney-in-fact, with full power of substitution, to transfer said stock on the books of the Company. THIS ASSIGNMENT
MAY ONLY BE USED AS AUTHORIZED BY THE AGREEMENT AND ANY EXHIBITS THERETO. 
  

					
	Dated:	 	  
	  	
		 		  	HOLDER
			
		 		  	  

		 		  	 (Signature)
  

Alan D. Gold

		 		  	(Please Print Name)

 Instructions to Holder: Please do not fill in any blanks other than the signature line. The purpose of
this Stock Power and Assignment is to enable the Company and/or its assignee(s) to acquire the shares pursuant to the Forfeiture Restriction set forth in the Agreement without requiring an additional signature on the part of the Holder.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]